scholarly article | Q13442814 |
P50 | author | Martin Hrabě de Angelis | Q28606776 |
Gabriele Möller | Q38549034 | ||
Anna Halama | Q57335813 | ||
P2093 | author name string | J Adamski | |
N Riesen | |||
P2860 | cites work | The human serum metabolome | Q21135549 |
Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum | Q21145030 | ||
Discovery of sexual dimorphisms in metabolic and genetic biomarkers | Q21563382 | ||
Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks | Q24646495 | ||
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression | Q24654019 | ||
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
Metabolomics and cardiovascular biomarker discovery | Q26991473 | ||
The Chemical Translation Service--a web-based tool to improve standardization of metabolomic reports | Q27062596 | ||
Human metabolic individuality in biomedical and pharmaceutical research | Q28247002 | ||
Cyclin-dependent kinases 4 and 6 control tumor progression and direct glucose oxidation in the pentose cycle | Q28268021 | ||
Metabolic profiles of cancer cells | Q28269762 | ||
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance | Q28279396 | ||
Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines | Q28474545 | ||
'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data | Q29784220 | ||
Normal human lymphocytes exhibit a wide range of methionine-dependency which is related to altered cell division but not micronucleus frequency | Q30663211 | ||
Metabolomics using 1H-NMR of apoptosis and Necrosis in HL60 leukemia cells: differences between the two types of cell death and independence from the stimulus of apoptosis used | Q33316515 | ||
Metabolite profiling of fecal water extracts from human colorectal cancer | Q33384170 | ||
Metabolic profiling reveals distinct variations linked to nicotine consumption in humans--first results from the KORA study | Q33389830 | ||
Systems biologists seek fuller integration of systems biology approaches in new cancer research programs | Q33575940 | ||
metaP-server: a web-based metabolomics data analysis tool | Q33714742 | ||
Reliability of serum metabolite concentrations over a 4-month period using a targeted metabolomic approach | Q33941155 | ||
A genome-wide perspective of genetic variation in human metabolism | Q34090221 | ||
The dynamic range of the human metabolome revealed by challenges | Q34198882 | ||
Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns | Q34272296 | ||
Bayesian independent component analysis recovers pathway signatures from blood metabolomics data | Q34309110 | ||
A novel serum metabolomics-based diagnostic approach for colorectal cancer | Q34336333 | ||
Noninvasive real-time imaging of apoptosis | Q34429029 | ||
Evidence for an alternative glycolytic pathway in rapidly proliferating cells | Q34535762 | ||
Cancer. Systems biology, metabolomics, and cancer metabolism | Q34638564 | ||
Serum amino acid profiles and their alterations in colorectal cancer | Q34660782 | ||
Mass spectrometry: from proteomics to metabolomics and lipidomics | Q34988633 | ||
Extending biochemical databases by metabolomic surveys | Q35084955 | ||
Monitoring apoptosis and neuronal degeneration by real-time detection of phosphatidylserine externalization using a polarity-sensitive indicator of viability and apoptosis. | Q35121508 | ||
Opportunities for studying cancer by metabolomics: preliminary observations on tumors deficient in hypoxia-inducible factor 1. | Q35147420 | ||
Application of metabolomics to prostate cancer | Q35234286 | ||
Protein biomarkers for the early detection of breast cancer | Q35367572 | ||
Apoptosis in the development and treatment of cancer | Q35890843 | ||
Glycomics: a pathway to a class of new and improved therapeutics | Q35906116 | ||
Genome-wide association studies with metabolomics | Q36245152 | ||
Novel biomarkers for pre-diabetes identified by metabolomics | Q36321634 | ||
Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease | Q36325036 | ||
Human serum metabolic profiles are age dependent | Q36498753 | ||
Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosis | Q36620298 | ||
Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover | Q36942649 | ||
Clinical applications of metabolomics in oncology: a review | Q37177549 | ||
From differentiating metabolites to biomarkers | Q37412408 | ||
Effects of sample handling and storage on quantitative lipid analysis in human serum | Q37478161 | ||
Metabolomics, a novel tool for studies of nutrition, metabolism and lipid dysfunction | Q37582618 | ||
Rapid changes in specific estrogen binding elicited by cGMP or cAMP in cytosol from human endometrial cells | Q37610054 | ||
Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS/MS becoming an essential tool for patient diagnosis | Q37699692 | ||
Challenges in mass spectrometry based targeted metabolomics | Q37701481 | ||
Molecular epidemiology and its current clinical use in cancer management | Q37722954 | ||
Molecular recognition mechanisms for detecting cell death in vivo | Q37760227 | ||
Cell culture metabolomics: applications and future directions | Q37769930 | ||
Targeted metabolomics for biomarker discovery. | Q37772442 | ||
Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect | Q37783380 | ||
Metabolomics and bladder cancer | Q37935192 | ||
Metabolomics: a revolution for novel cancer marker identification | Q37973424 | ||
Nutrigenomics: implications for breast and colon cancer prevention | Q37987513 | ||
Metabolomics in cancer: a bench-to-bedside intersection | Q37994896 | ||
Novel methodologies in metabolic profiling with a focus on molecular diagnostic applications | Q38019000 | ||
The kynurenine pathway in brain tumor pathogenesis. | Q38059195 | ||
Regulation of the metabolite profile by an APC gene mutation in colorectal cancer | Q39387564 | ||
An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression | Q39439986 | ||
Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing | Q39547930 | ||
Metabolic signatures in apoptotic human cancer cell lines | Q39589801 | ||
Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer | Q39672706 | ||
Metabolic signatures of malignant progression in prostate epithelial cells. | Q39679748 | ||
Characterization of 1H NMR detectable mobile lipids in cells from human adenocarcinomas. | Q39884998 | ||
Histone deacetylase inhibition results in a common metabolic profile associated with HT29 differentiation | Q40310696 | ||
Increases in NMR-visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells. | Q40428146 | ||
Systems medicine and the integration of bioinformatic tools for the diagnosis of Alzheimer's disease | Q41661052 | ||
Standards, databases, and modeling tools in systems biology | Q42681438 | ||
Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1 | Q42729073 | ||
Variation in the human lipidome associated with coffee consumption as revealed by quantitative targeted metabolomics | Q43265820 | ||
Metabotyping of biofluids reveals stress-based differences in gut permeability in healthy individuals | Q43279696 | ||
5-Fluorouracil (5-FU) induced apoptosis in gastric cancer cell lines: role of the p53 gene | Q44674846 | ||
Taurine inhibits apoptosis by preventing formation of the Apaf-1/caspase-9 apoptosome | Q44978497 | ||
A metabolomic approach to lung cancer | Q45297639 | ||
A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease | Q47401613 | ||
Estrogens, enzyme variants, and breast cancer: a risk model. | Q51933161 | ||
BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer. | Q53542028 | ||
Studies on associations of glycolytic and glutaminolytic enzymes in MCF-7 cells: role of P36. | Q54413378 | ||
Assay Tools for Metabolomics | Q59157152 | ||
Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics | Q59157191 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | biomarker | Q864574 |
metabolomics | Q12149006 | ||
P304 | page(s) | 425-439 | |
P577 | publication date | 2013-11-01 | |
P1433 | published in | Journal of Internal Medicine | Q6295387 |
P1476 | title | Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: tools for individualized medicine | |
P478 | volume | 274 |
Q26772073 | Blood transcriptomics and metabolomics for personalized medicine |
Q50973215 | Change of the metabolomic profile during short-term mononuclear cell storage. |
Q33745104 | Combining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls |
Q90588753 | Decoding the metabolic landscape of pathophysiological stress-induced cell death in anucleate red blood cells |
Q92645779 | Differential diagnosis between hepatocellular carcinoma and cirrhosis by serum amino acids and acylcarnitines |
Q38787802 | Distinct Metabolic Signature of Human Bladder Cancer Cells Carrying an Impaired Fanconi Anemia Tumor-Suppressor Signaling Pathway |
Q38698193 | Experimental design and reporting standards for metabolomics studies of mammalian cell lines |
Q39044824 | Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation |
Q33707386 | Globally Optimized Targeted Mass Spectrometry: Reliable Metabolomics Analysis with Broad Coverage |
Q52366931 | IntLIM: integration using linear models of metabolomics and gene expression data. |
Q64101021 | Investigating the deregulation of metabolic tasks via Minimum Network Enrichment Analysis (MiNEA) as applied to nonalcoholic fatty liver disease using mouse and human omics data |
Q93017936 | LC-MS metabolomics comparisons of cancer cell and macrophage responses to methotrexate and polymer-encapsulated methotrexate |
Q44539143 | Lessons learned and challenges posed in cancer genetics. Introduction |
Q34091261 | Long term conservation of human metabolic phenotypes and link to heritability |
Q33738817 | Metabolic characterization of invaded cells of the pancreatic cancer cell line, PANC-1. |
Q35844833 | Metabolic signatures differentiate ovarian from colon cancer cell lines |
Q34671698 | Metabolomics identifies the intersection of phosphoethanolamine with menaquinone-triggered apoptosis in an in vitro model of leukemia |
Q50090010 | Metabolomics toward personalized medicine. |
Q47111053 | Monitoring for Response to Antineoplastic Drugs: The Potential of a Metabolomic Approach. |
Q47106277 | Multi-omics analysis reveals that ornithine decarboxylase contributes to erlotinib resistance in pancreatic cancer cells |
Q57523698 | Optimisation of in vitro sample preparation for LC-MS metabolomics applications on HepaRG cell cultures |
Q35096373 | Perioperative dynamics and significance of amino acid profiles in patients with cancer |
Q38826371 | Programmed cell death in periodontitis: recent advances and future perspectives |
Q58778499 | Urea influences amino acid turnover in bovine cumulus-oocyte complexes, cumulus cells and denuded oocytes, and affects in vitro fertilization outcome |
Q36109560 | Urine metabolomic profiling of children with respiratory tract infections in the emergency department: a pilot study |
Search more.